Role of immune checkpoint inhibitor-based therapies for metastatic renal cell carcinoma in the first-line setting: A Bayesian network analysis

BACKGROUND: Several novel immune checkpoint inhibitor (ICI)-based treatments exhibited promising survival benefits for metastatic renal cell carcinoma (mRCC), yet there is no current guidance regarding the optimum first-line regimen. We performed this network analysis to compare the efficacy and saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Junpeng, Li, Xin, Wu, Xiaoqiang, Wang, Zhiwei, Zhang, Chan, Cao, Guanghui, Zhang, Xiaofan, Peng, Feng, Yan, Tianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796578/
https://www.ncbi.nlm.nih.gov/pubmed/31439476
http://dx.doi.org/10.1016/j.ebiom.2019.08.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796578/
https://www.ncbi.nlm.nih.gov/pubmed/31439476
http://dx.doi.org/10.1016/j.ebiom.2019.08.006

Ejemplares similares